Learn more

BANC DE SANG I TEIXITS

Overview
  • Total Patents
    23
  • GoodIP Patent Rank
    227,907
  • Filing trend
    ⇩ 100.0%
About

BANC DE SANG I TEIXITS has a total of 23 patent applications. It decreased the IP activity by 100.0%. Its first patent ever was published in 2009. It filed its patents most often in WIPO (World Intellectual Property Organization), Spain and Mexico. Its main competitors in its focus markets biotechnology, pharmaceuticals and medical technology are IHEART JAPAN CORP, CELLTRAN LTD and ODONTIS LTD.

Patent filings per year

Chart showing BANC DE SANG I TEIXITSs patent filings per year from 1900 to 2020

Top inventors

# Name Total Patents
#1 Cairo Badillo Jordi Joan 11
#2 Pla Calvet Pablo Arnau 10
#3 Garcia Lopez Juan 10
#4 Godia Casablancas Francesc 8
#5 Vives Armengol Joaquim 7
#6 Garcia Lopez Joan 7
#7 Caminal Bobet Marta 6
#8 Pla Calvet Arnau 6
#9 Oliver Vila Irene 6
#10 Rodriguez Gomez Luciano 5

Latest patents

Publication Filing date Title
EP3456363A1 Composition for regenerating bony tissue, method for preparation and use thereof
WO2013083149A1 Apparatus for handling and transporting deformable plastic containers for liquids
WO2013083148A1 Method and system for manipulating blood related product bags
ES2377796A1 PROCEDURE TO PREPARE PRODUCTS OF CELLULAR THERAPY OR TISSULAR ENGINEERING.
ES2368394A1 COMPOSITION THAT INCLUDES PLASMA DE SANGRE DE CORDON UMBILICAL FOR THE TREATMENT OF PATHOLOGIES OF THE EYE SURFACE AND PROCEDURE FOR OBTAINING THE SAME.
ES2362021A1 PROCEDURE FOR OBTAINING A TISSULAR ENGINEERING PRODUCT ORIENTED TO THE REGENERATION OF CARTILAGINOUS TISSUE.
EP2361971A1 Procedure for obtaining a tissue engineering product for the regeneration of bone tissue
WO2010142784A2 Use of gelled prp (platelet gel) for volumetric breast reconstruction
ES2336637A1 PROCEDURE FOR EXPANSION PARALLY INDIFFERENTIATED OR ORIENTED TO MYELOID LINE OF HEMATOPOYTIC MOTHER CELLS FROM BLOOD OF CORDONUMBILICAL, MOVILIZED PERIPHERAL BLOOD OR OSEA MEDULA.
ES2324011A1 PROCEDURE FOR OBTAINING MESENQUIMAL MOTHER CELLS FROM THE MONONUCLEAR FRACTION OF THE HUMAN OSEA MEDULA.